WPRIM Management System> DCMS> Cancer Research and Treatment> 2003> 35> 1

Volume: 35 Issue: 1

1. Site-Specific Mutagenesis in Escherichia coli by Bulky Exocyclic Amino-Substituted Guanine and Adenine Derivatives in Double-Stranded or Gapped Plasmids. Page:75—80
2. Clinical Experience in Conformal Stereotactic Radiotherapy of Irregularly Shaped Intracranial Tumors. Page:69—74
3. The Efficacy and Safety of DA-3030 (Recombinant Human Granulocyte Colony-Stimulating Factor) in Neutropenia after the Remission Induction Chemotherapy in Patients with Acute Myelogenous Leukemia. Page:66—68
4. Correlation between Retinoic Acid Sensitivity and IGFBP-3, AFP Protein Expression in Hepatoma Cell Lines. Page:59—65
5. The Effect of More Aggressive Surgery in Esophageal Cancer. Page:52—58
6. The Estimation of Breast Cancer Disease-Probability by Difference of Individual Susceptibility. Page:35—51
7. A Multi-Center, Phase II Clinical Trial of Genexol(R) (Paclitaxel) and Cisplatin for Patients with Non-Small Cell Lung Cancer. Page:30—34
8. Phase I and Pharmacokinetic Study of Intraoperative Intraperitoneal Heptaplatin in Patients with Surgically Resected Advanced Gastric Cancer. Page:25—29
9. RImmunohistochemical Evaluation of E-cadherin/catenin (alpha-, beta-, gamma-catenin and p120CTN) Complex Expression in Early Gastric Cancer. Page:16—24
10. Overexpression of c-met Protein in Gastric Cancer and Role of uPAR as a Therapeutic Target. Page:9—15
11. The Serum Assay of Soluble CD44 Standard, CD44 Variant 5, and CD44 Variant 6 in Patients with Gastric Cancer. Page:3—8
12. Molecular Markers in Gastric Cancer: Can They Predict Prognosis?. Page:1—2

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.